WAM
ALXN

Wolverine Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Wolverine Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-60
Closed -$1K – 1957
2015
Q4 		$1K Hold
60
– – ﹤0.01% 1649
2015
Q3 		$40K Hold
60
– – ﹤0.01% 1325
2015
Q2 		$24K Hold
60
– – ﹤0.01% 1456
2015
Q1 		$41K Buy
+60
New +$10.9K ﹤0.01% 1302
2014
Q4 		– Sell
-82
Closed -$77K – 2840
2014
Q3 		$77K Buy
+82
New +$13.5K ﹤0.01% 1390
2014
Q1 		– Sell
-71
Closed -$22K – 3124
2013
Q4 		$22K Hold
71
– – ﹤0.01% 2045
2013
Q3 		$126K Buy
+71
New +$7.79K ﹤0.01% 1366

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return